secwatch.observer — SEC 8-K summary
======================================

Issuer:     cbdMD, Inc. (YCBD)
CIK:        0001644903
Form:       8-K
Filed at:   2025-11-28T23:59:59+00:00
Accession:  0001437749-25-036497
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

cbdMD enters new 3-year CEO employment agreement with $340k base salary, 445k restricted share award subject to approval
--------------------------------------------------------------------------------

- CEO/CFO T. Ronan Kennedy signs 3-year term; base salary of $340,000 per year.
- Granted 445,000 restricted shares under new 2025 Equity Plan; vesting conditioned on shareholder approval.
- Board approved 2025 Equity Compensation Plan reserving 891,316 shares, with evergreen formula up to 2% annually.
- Quarterly performance bonus target up to $140k annually, with potential escalator to $175k based on positive EBITDA.
- Severance: if terminated without cause, receives base salary for balance of term (minimum 12 months) and full equity acceleration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644903/000143774925036497/0001437749-25-036497-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644903/000143774925036497/ycbd20251128_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-036497

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer